A special focus on the vaccine industry.  
Home What we do Our approach Our products Our location Help us Contact us
Our Products:
MarketVIEW (all vaccines)
MasterVIEW (novel vaccines)
ExpertREACT (newsletter)

Company Brochure:
Summer 2022



Other Research:
A.baumannii vaccines forecast
Staphylococcus aureus BSI/SSI vaccines (USA)
mRNA vaccines - infectious diseases
ExPEC vaccines forecast
HPV therapeutic vaccines forecast
Shigella vaccines forecast
Dengue vaccines (travelers)
Opioid use disorder vaccines forecast
Pertussis booster vaccines
Cholera vaccines
Universal influenza vaccines
Zika virus vaccines
HBV vaccines
H. pylori vaccines
More...
Home
VacZine Analytics is a strategic research publisher based in the United Kingdom since 2007.

We provide high-quality disease and commercial analysis to those working within or in collaboration with the vaccine industry.

Our key focus is helping clients build the case for developing new vaccines and immune-based therapies.

Join Our Email List

Latest Research
Seasonal influenza vaccines forecast Q4 '22 Soon!
Vaccines/mRNA Strategic Pipeline Review Aug '22 SAMPLE
Respiratory Syncytial Virus vaccines/mAb forecast July '22
Herpes Simplex Virus vaccines TX forecast June '22
Herpes Simplex Virus vaccines PX forecast June '22
Epstein-Barr virus vaccines forecast Mar '22
Congenital Cytomegalovirus vaccines forecast Apr '22
Nipah (Henipavirus) vaccines forecast Q1 '22
Periodontal disease vaccines forecast Q1 '22
Respiratory virus vaccines segment forecast Sept '21
Dengue endemic vaccines forecast Sept '21
INTERACTIVE Coronavirus [COVID-19] vaccines forecast Order SAMPLE
New vaccine products USA forecast Order
Chikungunya vaccines forecast Sept '20
Rift Valley Fever vaccines forecast July '20
Norovirus vaccines forecast June '20
MERS-CoV vaccines forecast Jan '20
Lassa fever vaccines forecast Nov '19
Lyme Borreliosis vaccines forecast June '19
Campylobacter vaccines forecast June '19
Latest News
© 2022 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. We are an equal opportunities employer.